Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biotech M&A Could Finally Perk Up in 2022 By: ETF Trends December 27, 2021 at 13:15 PM EST Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren’t enough aimed at smaller biotechnology companies. As is often the case, market observers are forecasting an uptick in biotechnology consolidation activity next year.... Read More >> Related Stocks: Alps Medical Breakthroughs ETF Nasdaq Biotechnology Ishares ETF Vaneck Biotech ETF Virtus Lifesci Biotech Clinical Trials ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Biotech M&A Could Finally Perk Up in 2022 By: ETF Trends December 27, 2021 at 13:15 PM EST Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren’t enough aimed at smaller biotechnology companies. As is often the case, market observers are forecasting an uptick in biotechnology consolidation activity next year.... Read More >> Related Stocks: Alps Medical Breakthroughs ETF Nasdaq Biotechnology Ishares ETF Vaneck Biotech ETF Virtus Lifesci Biotech Clinical Trials ETF